Epigenetic biomarkers: A new perspective in laboratory diagnostics

J L García-Giménez1, F Sanchis-Gomar, G Lippi

  • 1CIBERER, The Biomedical Network Research Centre on Rare Diseases. Valencia, Spain. j.luis.garcia@uv.es

Summary

Epigenetic modifications, including DNA methylation and histone changes, are key to gene regulation. New technologies enable their use as biomarkers for diseases like cancer and neurodegenerative disorders.